menu
    • menu

    Company profile for Faron Pharmaceuticals

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Faron PharmaceuticalsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Joukahaisenkatu 6 FI-20520 TURKU
    Telephone
    Telephone
    +358 2 469 5151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.faron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faron Pharma Announces Directorate Appointment
    Faron Pharma Announces Directorate Appointment

    05 May 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-directorate-appointment-1163798

    ACCESSWIRE
    05 May 2026
    Share Share
    Faron Pharma Ltd: Key Company Holdings
    Faron Pharma Ltd: Key Company Holdings

    05 May 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-holdings-in-company-1163807

    ACCESSWIRE
    05 May 2026
    Share Share
    Faron Pharmaceuticals Ltd: Results Of The Annual General Meeting
    Faron Pharmaceuticals Ltd: Results Of The Annual General Meeting

    04 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-04/faron-pharmaceuticals-ltd-results-of-the-annual-general-meeting

    PHARMIWEB
    04 May 2026
    Share Share
    Faron Pharmaceuticals Ltd: Holding(s) In Company
    Faron Pharmaceuticals Ltd: Holding(s) In Company

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/faron-pharmaceuticals-ltd-holding-s-in-company

    PHARMIWEB
    22 Apr 2026
    Share Share
    Faron Pharma Ltd: Holdings Overview
    Faron Pharma Ltd: Holdings Overview

    16 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-16/faron-pharmaceuticals-ltd-holding-s-in-company

    PHARMIWEB
    16 Apr 2026
    Share Share
    Faron Collaborates With Parexel For Phase IIb BEXERA Trial
    Faron Collaborates With Parexel For Phase IIb BEXERA Trial

    16 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-16/faron-announces-collaboration-with-parexel-to-support-phase-iib-bexera-trial-in-treatment-naïve-hr-m

    PHARMIWEB
    16 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search